Last reviewed · How we verify
Topical betamethasone 0.05%
Topical betamethasone 0.05% is a Small molecule drug developed by Post Graduate Institute of Medical Education and Research, Chandigarh. It is currently FDA-approved.
At a glance
| Generic name | Topical betamethasone 0.05% |
|---|---|
| Sponsor | Post Graduate Institute of Medical Education and Research, Chandigarh |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Trial to Demonstrate That the Dual Laser Therapy is Effective for the Treatment of Vulvar Lichen Sclerosus (NA)
- Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited Vitiligo (EARLY_PHASE1)
- URGO FilmoCream Eczema + Dermocorticoids in Atopic Dermatitis (NA)
- The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery) (PHASE4)
- Laser vs Clobetasol for Lichen Sclerosus (PHASE3)
- Comparison of Efficacy of Betamethasone Gel With Lidocaine Gel in Prevention of Post Endotracheal Intubation Sore Throat. (PHASE1, PHASE2)
- Treatment of Vulvar Lichen Sclerosus With Corticosteroid Ointment, Calcineurin Inhibitor Ointment, and Platelet-Rich Plasma (PRP) Therapy. (NA)
- Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Topical betamethasone 0.05% CI brief — competitive landscape report
- Topical betamethasone 0.05% updates RSS · CI watch RSS
- Post Graduate Institute of Medical Education and Research, Chandigarh portfolio CI
Frequently asked questions about Topical betamethasone 0.05%
What is Topical betamethasone 0.05%?
Topical betamethasone 0.05% is a Small molecule drug developed by Post Graduate Institute of Medical Education and Research, Chandigarh.
Who makes Topical betamethasone 0.05%?
Topical betamethasone 0.05% is developed and marketed by Post Graduate Institute of Medical Education and Research, Chandigarh (see full Post Graduate Institute of Medical Education and Research, Chandigarh pipeline at /company/post-graduate-institute-of-medical-education-and-research-chandigarh).
What development phase is Topical betamethasone 0.05% in?
Topical betamethasone 0.05% is FDA-approved (marketed).